Abstract
The generation of mutant H5N1 flu virus raised fundamental questions about the assessment and management of the risks of dual‐use biological research. Governments might well increase oversight and regulation to rectify the current shortcomings.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
